Zentalis Pharmaceuticals, Inc. ($ZNTL)
Bruns Ingmar โ Chief Medical Officer
Shares
335
Price
$2.39
Total Value
$801.62
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Bruns Ingmar |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Feb 9, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 6, 2026 |
| Shares Sold | 335 |
| Price per Share | $2.39 |
| Total Value | $801.62 |
| Shares Owned After | 33,332 |
| Derivative | No |
| Accession Number | 0001838041-26-000004 |
| Document | View SEC Filing |